Table: Sapporo Clinical Lab -Q1 group results

Sapporo Clinical Laboratory

07/08/2017 07:30

Aug 7 (Reuters)-  
             Sapporo Clinical Laboratory Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended       Year to  
                Jun 30, 2017        Jun 30, 2016     Mar 31, 2018  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             4.38                4.24             17.70     
                 (+3.3 pct)          (-1.5 pct)       (+3.8 pct)   
  Operating        277 mln             110 mln          751 mln    
                (+150.4 pct)         (-58.8 pct)      (-2.6 pct)   
  Recurring        288 mln             127 mln          778 mln    
                (+126.6 pct)         (-54.1 pct)      (-3.1 pct)   
  Net              192 mln             80 mln           522 mln    
                (+139.9 pct)         (-53.4 pct)      (+1.8 pct)   
  EPS             55.22 yen           23.01 yen       150.28 yen   
  Ann Div                             10.00 yen        10.00 yen   
  -Q2 div                                NIL              NIL      
  -Q4 div                             10.00 yen        10.00 yen   
   
  NOTE - Sapporo Clinical Laboratory Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T  
  ((Tokyo Headline News Desk +813 6441 1812))